Harmony Biosciences Holdings, Inc. HRMY Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $32.49M-28.7% | $22.49M-54.6% | $50.87M+10.4% | $39.78M+243% | $45.56M+18.9% | ||
| $7K0.0% | —— | $7K0.0% | $6K-93.4% | $7K-95.7% | ||
| $10.62M-15.0% | $9.97M-1.0% | $10.97M-0.7% | $11.46M+3.3% | $12.5M+20.3% | ||
| -$3.86M+10.4% | —— | -$3.88M+19.6% | -$6.49M+54.6% | -$4.31M-24.0% | ||
| $11.44M-50.1% | —— | $7.67M— | —— | $22.94M+311% | ||
| -$76K+90.7% | -$1.53M-639% | —— | -$284K— | -$814K-265% | ||
| $10.91M+194% | —— | —— | $10.84M+76.6% | $3.72M+244% | ||
| $3M+49.9% | -$24.85M— | -$12.53M-1,579% | $3.59M+535% | $2M-41.9% | ||
| -$46.18M-746% | $52.45M+317% | $28.03M+15.2% | -$7.03M+58.3% | -$5.46M+33.7% | ||
| $560K+19.9% | $402K-16.4% | $0-100% | $465K-29.4% | $467K0.0% | ||
| $5.96M0.0% | $5.96M0.0% | $5.96M0.0% | $5.96M0.0% | $5.96M0.0% | ||
| $27.76M-18.3% | $126.15M+67.0% | $108.73M+54.2% | $79.33M+86.1% | $33.99M+9.1% | ||
| —— | $107K-79.1% | $71K+2,267% | $4K-99.4% | $128K+2,460% | ||
| $179M+836% | $18.84M-47.2% | $24.28M+4.3% | $23.9M+12.7% | $19.13M-23.8% | ||
| $27.35M+26.5% | $20.56M-31.5% | $19.56M-18.6% | $19.32M-24.4% | $21.62M+14.3% | ||
| -$183.65M-7,875% | -$17.63M-145% | -$4.79M— | -$19.59M+64.3% | $2.36M+138% | ||
| $5M+33.3% | $5M+33.3% | $3.75M0.0% | $3.75M0.0% | $3.75M0.0% | ||
| $347K-92.6% | $2.65M-18.2% | $754K-70.7% | $2.1M+266% | $4.71M+3,957% | ||
| $2.57M+96.1% | $663K-70.2% | $0— | $1.03M— | $1.31M— | ||
| -$7.22M-1,951% | -$3.02M-10.0% | -$3M-155% | -$2.69M+22.1% | -$352K+90.3% | ||
| -$163.1M-553% | $105.5M+60.7% | $100.95M+44.1% | $57.05M— | $36M+68.8% | ||
| $3.32M-20.8% | $3.52M-15.2% | $3.51M-17.0% | $3.46M-20.6% | $4.2M-8.5% | ||
| $220K-51.2% | $281K-42.8% | $336K-38.9% | $453K-27.6% | $451K-24.1% | ||
| $151K-9.0% | $157K-7.1% | $161K-8.0% | $163K-7.4% | $166K-7.8% | ||
| $5.96M0.0% | $5.96M0.0% | $5.96M0.0% | $5.96M0.0% | $5.96M0.0% | ||
| $7K0.0% | —— | $7K0.0% | $6K-93.4% | $7K-95.7% | ||
| —— | $372.5K+458% | $372.5K+458% | $372.5K+458% | $372.5K+458% | ||
| $32M— | $4.25M+325% | $15M— | —— | —— | ||
| $10.91M+194% | —— | —— | $10.84M+76.6% | $3.72M+244% | ||
| $3M+49.9% | -$24.85M— | -$12.53M-1,579% | $3.59M+535% | $2M-41.9% | ||
| -$312K-537% | $320K— | -$145K-136% | -$61K+51.2% | -$49K-223% | ||
| $32M+753% | $3.75M-41.2% | $3.75M-41.2% | $3.75M-41.2% | $3.75M-41.2% | ||
| $27.35M+26.5% | $20.56M-31.5% | $19.56M-18.6% | $19.32M-24.4% | $21.62M+14.3% | ||
| —— | $126.04M+67.9% | $108.66M+54.1% | $79.32M+88.9% | $33.86M+8.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Harmony Biosciences Holdings, Inc.'s cash flow data come from?
- Every line is extracted from Harmony Biosciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.